Table 3 Correlations between serum magnesium and various clinico-laboratory data among the studied children and adolescents with T1DM and controls.

From: Magnesium, fibrinolysis and clotting interplay among children and adolescents with type 1 diabetes mellitus; potential mediators of diabetic microangiopathy

 

Serum magnesium

Children and adolescents with T1DM and controls (n=46)

Controls (n=46)

r

P value

r

P value

Age (years)

0.223

0.137

0.004

0.976

Diabetes Duration (years)

−0.247

0.098

-

-

Insulin daily dose (unit/kg/day)

−0.244

0.042*

-

-

PT (seconds)

0.856

<0.001*

0.181

0.288

APTT (seconds)

0.808

<0.001*

0.070

0.964

PAI-I (ng/ml)

−0.643

<0.001*

−0.120

0.325

HbA1c %

−0.294

0.023*

-

-

Urinary micro albumin mg/gm creatinine

−0.286

0.036*

-

-

Cholesterol (mg/dl)

−0.045

0.769

0.001

0.995

Triglycerides (mg/dl)

−0.467

0.001*

0.141

0.351

HDL (mg/dl)

0.382

0.009*

-0.004

0.982

LDL (mg/dl)

−0.100

0.510

0.048*

0.751

  1. Spearman correlation co-efficient, r: correlation co-efficient, Bold and asterisk (*): significant.
  2. PT Prothrombin time, APTT Activated Partial Thromboplastin Time, PAI-I Plasminogen Activator Inhibitor Type-1, HDL High-density lipoprotein, LDL Low-density lipoprotein.
Back to article page